Search all trials

Find therapies in clinical trials near you – page 26

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Study on Andexanet Alfa for Patients on Factor Xa Inhibitors (Apixaban, Rivaroxaban, Edoxaban) Needing Urgent Surgery to Reduce Bleeding Risk

Not recruiting

Registered drugNo placebo

Study on Andexanet Alfa for Patients on Factor Xa Inhibitors (Apixaban, Rivaroxaban, Edoxaban) Needing Urgent Surgery to Reduce Bleeding Risk

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Aminocaproic Acid

Contact Research Centre

Chronic hepatitis B+1

Not recruiting

Investigational

Study of Bepirovirsen for Patients with Chronic Hepatitis B on Nucleos(t)ide Analogue Treatment

Investigational

Romania

Participants:18–64 years · 65+ years
Substances:Bepirovirsen

Contact Research Centre

Breast cancer+2

Not recruiting

Registered drugNo placebo

Study on Giredestrant and Fulvestrant with CDK4/6 Inhibitor for Patients with ER+ HER2-Negative Advanced Breast Cancer Resistant to Endocrine Therapy

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Abemaciclib

Contact Research Centre

Squamous cell carcinoma

Not recruiting

Registered drug

Study of Pembrolizumab as Additional Treatment for Patients with High-Risk Locally Advanced Cutaneous Squamous Cell Carcinoma After Surgery and Radiation

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Hepatitis D

Not recruiting

Registered drugNo placebo

Study on Bulevirtide Treatment for Patients with Chronic Hepatitis D

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Bulevirtide

Contact Research Centre

Lipoprotein metabolism disorder

Not recruiting

Investigational

Study of LY3819469 for Adults with High Lipoprotein(a) Levels

Investigational

Romania

Participants:18–64 years · 65+ years
Substances:Ly3819469 Sodium

Contact Research Centre

Epilepsy

Not recruiting

InvestigationalNo placebo

Long-Term Safety Study of Lacosamide for Children with Epilepsy

InvestigationalNo placebo

Romania

Participants:0–17 years
Substances:Lacosamide

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with Low PD-L1 Levels

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Non-small cell lung cancer metastatic

Not recruiting

Registered drugNo placebo

Study Comparing Subcutaneous Pembrolizumab with Hyaluronidase to Intravenous Pembrolizumab and Chemotherapy for First-line Treatment of Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Bladder cancer

Not recruiting

Registered drug

Study of Pembrolizumab with Chemoradiotherapy for Patients with Muscle-Invasive Bladder Cancer

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Cisplatin

Contact Research Centre

Cardiovascular disorder

Not recruiting

Registered drug

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid

Contact Research Centre

COVID-19

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Bemnifosbuvir for High-Risk COVID-19 Patients

Registered drug

Romania

Participants:0–17 years · 18–64 years · 65+ years
Substances:Nirmatrelvir

Contact Research Centre

Find therapies in clinical trials near you – page 26

319 trials match your criteria

Study on Andexanet Alfa for Patients on Factor Xa Inhibitors (Apixaban, Rivaroxaban, Edoxaban) Needing Urgent Surgery to Reduce Bleeding Risk

Study on Andexanet Alfa for Patients on Factor Xa Inhibitors (Apixaban, Rivaroxaban, Edoxaban) Needing Urgent Surgery to Reduce Bleeding Risk

Chronic hepatitis B+1

Study of Bepirovirsen for Patients with Chronic Hepatitis B on Nucleos(t)ide Analogue Treatment

Breast cancer+2

Study on Giredestrant and Fulvestrant with CDK4/6 Inhibitor for Patients with ER+ HER2-Negative Advanced Breast Cancer Resistant to Endocrine Therapy

Squamous cell carcinoma

Study of Pembrolizumab as Additional Treatment for Patients with High-Risk Locally Advanced Cutaneous Squamous Cell Carcinoma After Surgery and Radiation

Hepatitis D

Study on Bulevirtide Treatment for Patients with Chronic Hepatitis D

Lipoprotein metabolism disorder

Study of LY3819469 for Adults with High Lipoprotein(a) Levels

Epilepsy

Long-Term Safety Study of Lacosamide for Children with Epilepsy

Non-small cell lung cancer

Study of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with Low PD-L1 Levels

Non-small cell lung cancer metastatic

Study Comparing Subcutaneous Pembrolizumab with Hyaluronidase to Intravenous Pembrolizumab and Chemotherapy for First-line Treatment of Metastatic Non-Small Cell Lung Cancer

Bladder cancer

Study of Pembrolizumab with Chemoradiotherapy for Patients with Muscle-Invasive Bladder Cancer

Cardiovascular disorder

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

COVID-19

Study on the Effectiveness and Safety of Bemnifosbuvir for High-Risk COVID-19 Patients

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.